|
Orthologous residues
|
|
eNOS (human): S1177‑p, eNOS (mouse): S1176‑p, eNOS (rat): S1176‑p, eNOS (rabbit): S1183‑p, eNOS (pig): S1179‑p, eNOS (cow): S1179‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
phospho-antibody, western blotting
|
|
Relevant cell lines - cell types - tissues:
PAE (endothelial)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
pig
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
Akt1 (human)
|
phospho-antibody, transfection of constitutively active enzyme, pharmacological activator of upstream enzyme, pharmacological inhibitor of upstream enzyme, transfection of dominant-negative enzyme
|
|
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
H2O2
|
|
|
|
increase
|
|
|
LY294002
|
H2O2
|
|
|
inhibit treatment-induced increase
|
|
|
wortmannin
|
H2O2
|
|
|
inhibit treatment-induced increase
|
|
|
L-NAME
|
H2O2
|
|
|
no effect upon treatment-induced increase
|
|
|
PP2
|
H2O2
|
|
|
inhibit treatment-induced increase
|
|
|
AG1478
|
H2O2
|
|
|
inhibit treatment-induced increase
|
|
|
BAPTA-AM
|
H2O2
|
|
|
inhibit treatment-induced increase
|
|
|
Ro31-8220
|
H2O2
|
|
|
no effect upon treatment-induced increase
|
|
|
catalase
|
H2O2
|
|
|
inhibit treatment-induced increase
|
|
|